Private Wealth Management Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Private Wealth Management Group’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$735	Hold	13	–	–	﹤0.01%	1301
2025 Q4	$773	Hold	13	–	–	﹤0.01%	1316
2025 Q3	$705	Buy	13 +12	+1,200%	+$686	﹤0.01%	1364
2025 Q2	$55	Sell	1 -140	-99%	-$8.24K	﹤0.01%	1485
2025 Q1	$9.97K	Buy	141 +26	+23%	+$1.75K	﹤0.01%	474
2024 Q4	$7.56K	Buy	115 +10	+10%	+$670	﹤0.01%	583
2024 Q3	$7.38K	Sell	105 -26	-20%	-$2.17K	﹤0.01%	573
2024 Q2	$10.8K	Buy	131 +33	+34%	+$2.75K	﹤0.01%	426
2024 Q1	$8.56K	Sell	98 -28	-22%	-$2.51K	﹤0.01%	457
2023 Q4	$12.1K	Buy	+126	New	+$11.1K	0.01%	367

Other funds holding BMRN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return